Postinfectious Guillain-Barre syndrome in a patient with methimazole-induced agranulocytosis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Both Graves disease and Guillain-Barre syndrome (GBS) are autoimmune disorders caused by impaired self-tolerance mechanisms and triggered by interactions between genetic and environmental factors. GBS in patients who suffer from other autoimmune diseases is rarely reported, and the development of postinfectious GBS in a patient with Graves disease has not been previously reported in the literature. Herein, we report a patient with Graves disease who developed postinfectious GBS during a course of methimazole-induced agranulocytosis.
Abstract
Both Graves disease and Guillain-Barre syndrome (GBS) are autoimmune disorders caused by impaired self-tolerance mechanisms and triggered by interactions between genetic and environmental factors. GBS in patients who suffer from other autoimmune diseases is rarely reported, and the development of postinfectious GBS in a patient with Graves disease has not been previously reported in the literature. Herein, we report a patient with Graves disease who developed postinfectious GBS during a course of methimazole-induced agranulocytosis.
참고문헌 (9)
- Brent GA., "Clinical practice: Graves’ disease", N Engl J Med, 358, pp.2594~2605 (2008)
- Vucic S, "Guillain-Barré syndrome: an update", J Clin Neurosci, 16, pp.733~741 (2009)
- Guillain-Barre Syndrome Study Group, "Guillain-Barré syndrome: an Italian multicentre case-control study: Guillain-Barré Syndrome Study Group", Neurol Sci, 21, pp.229~234 (2000)
- van Doorn PA, "Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome", Lancet Neurol, 7, pp.939~950 (2008)
- Geleijns K, "HLA class II alleles are not a general susceptibility factor in Guillain- Barré syndrome", Neurology, 64, pp.44~49 (2005)
- Geleijns K, "Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients", J Neuroimmunol, 150, pp.132~138 (2004)
- Bersano A, "Long term disability and social status change after Guillain-Barré syndrome", J Neurol, 253, pp.214~218 (2006)
- van der Meche FG, "A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome: Dutch Guillain- Barré Study Group", N Engl J Med, 326, pp.1123~1129 (1992)
- Hughes RA, "Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology", Neurology, 61, pp.736~740 (2003)